Bookmark Email Print page

Life Sciences & Health Care

Improving the quality of care

The Global Life Sciences and Health care practice was born out of our Firm’s recognition of the unique opportunity presented to us by the enormous amount of growth and changes in that market. This industry was specifically identified in our Firm’s strategic assessment as a top priority for our global organization’s future growth and success.

Combining our life sciences and health care practices into a single global industry group is a natural step that enables us to achieve significant synergies and more quickly increase our competitive resources and capabilities.

Today, health organizations must balance quality care and accountability in an environment of increased costs allied to limited resources and funding.

Deloitte works extensively with a range of health providers and their suppliers, both in the public and private sector. Together with our clients, we aim to improve the quality of care while creating and sustaining long-term, bottom-line success.

We are also fully cognizant of the growing market in health tourism and are equipped to advise our clients on the latest trends and market needs.

Deloitte offers comprehensive, customized solutions that will assist you:

  • Build and sustain financial strength
  • Implement best practices
  • Mitigate risk and manage compliance
  • Accelerate innovation and growth.

We offer a wide spectrum of professional services, backed by years of health care experience. We provide a broad range of advisory skills including “evidence based” decision support, process improvement and activity based management services, alongside our traditional strengths in auditing, accounting, tax and financial advisory services.

Featured list

  • Physician perspectives about health information technology
    This survey of physicians assesses their current use and overall views of HIT, as well as actions around electronic health records, meaningful use, and ICD-10. Physicians believe in the value of HIT to improve quality and safety, however, the cost of HIT remains a major concern.
  • Accounting update for the life sciences industry
    We're pleased to present our annual life sciences industry publication, in this changing landscape, it is more important than ever to monitor and anticipate such events, which can affect transparency and other aspects of accounting & financial reporting.
  • 2011 Survey of the UAE healthcare sector
    As the government increasingly focuses its efforts on attracting more prestigious private healthcare providers, Deloitte Middle East’s newly released 2011 Survey of the UAE healthcare sector looks at the opportunities and challenges for private providers.
  • The pharmaceutical innovation dilemma
    Pharma innovation is facing a fundamental productivity challenge. Investment in R&D has outpaced sales growth, but this has not increased output of new medicines. Execs are seeking greater transparency in R&D decision making.

Learn more

  • The future of the life sciences industries: Transformation amid rising risk
    As life sciences companies face many challenges, survey results show how the industry is transforming during a period of increased risk.
  • Physician Perspectives About Health Information Technology
    Survey of physicians assesses their current use, overall views, and actions around HIT
  • Accounting Update for the Life Sciences Industry
    In this changing landscape, it is more important than ever to monitor and anticipate such events, which can affect transparency and other aspects of accounting & financial reporting.

Stay connected

  • Contact us
  • Careers
  • Submit RFP
  • Like us on Facebook
  • Follow us on Twitter
  • Join us on LinkedIn
  • Watch us on YouTube